首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >A Classic Herbal Formula Danggui Beimu Kushen Wan for Chronic Prostatitis: From Traditional Knowledge to Scientific Exploration
【24h】

A Classic Herbal Formula Danggui Beimu Kushen Wan for Chronic Prostatitis: From Traditional Knowledge to Scientific Exploration

机译:经典的草本方程式Dangui Beimu Kushen Wan慢性前列腺炎:从传统知识到科学勘探

获取原文
           

摘要

Chronic prostatitis (CP) is a chronic inflammation in the prostate with unsatisfactory management. Danggui Beimu Kushen Wan (DBKW) is a classic formula developed 1800 years ago for patients with difficult urination and it has been widely utilized for CP in modern days. However, scientific understanding of DBKW on CP has not been systematically reviewed. First, we searched the Encyclopedia of Traditional Chinese Medicine for the etiologies and pathogeneses of CP-like symptoms and DBKW and compared their similarities and differences from traditional Chinese medicine and conventional medicine perspectives. Then, we searched 21 electronic databases to identify potential clinical and experimental studies. Characteristics of included studies, ingredients, herb frequency, and possible mechanisms of actions were descriptively summarized. Risk of bias of randomized controlled trials (RCTs) was evaluated using the Cochrane risk of bias assessment tool. A total of 290 studies were identified. Six clinical studies, including four RCTs and two case series, and eight experimental studies were included. Clinical studies indicated that DBKW used alone or as an adjunct therapy significantly reduced the CP symptom scores and decreased the expressed prostatic secretions-pH when compared to antibiotics or α-blocker. Most RCTs have high or unclear risk of bias. Experimental studies revealed that DBKW may have effects on anti-inflammation, antibacteria, antioxidation, sex hormone regulation, and immunoregulation. DBKW demonstrated a great potential in the treatment of CP. High-quality RCTs and network pharmacological studies should be considered for future research.
机译:慢性前列腺炎(CP)是前列腺慢性炎症,令人满意的管理层。 Danggui Beimu Kushen Wan(DBKW)是一家经典的公式,为1800年前开发的患者,患有困难的患者,它已广泛用于现代日内CP。但是,对CP的DBKW的科学理解尚未得到系统审查。首先,我们搜查了中国中医的百科全书,用于CP样症状和DBKW的病因和病原因,并将其与中药和常规医学观点的相似性和差异进行了比较。然后,我们搜索了21个电子数据库以识别潜在的临床和实验研究。包括研究,成分,草药频率以及可能的行动机制的特征被描述为描述。使用偏差评估工具的Cochrane风险评估随机对照试验(RCT)的偏差风险。共鉴定了290项研究。包括六项临床研究,包括四个RCT和两个案例系列以及八项实验研究。临床研究表明,与抗生素或α-嵌体相比,单独使用或作为辅助治疗的DBKW单独使用或作为CP症状评分显着降低,并降低表达的前列腺分泌物-P-pH。大多数RCT都具有高或不明确的偏见风险。实验研究表明,DBKW可能对抗炎,抗菌,抗氧化,性激素调控和免疫调节产生影响。 DBKW在治疗CP治疗方面表现出很大的潜力。应考虑高质量的RCT和网络药理学研究以供未来的研究。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号